Drug Trial Radar · NCT00003129
Chemotherapy in Treating Patients With Early-Stage Bladder Cancer
Last checked: Nov 20, 2026Latest source record: Jun 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Planned (sponsor's estimate)
Start
Sep 1, 1998
Primary completion
Nov 2002
Study completion May 1, 2009
Sponsor
- Lead sponsor
- Eastern Cooperative Oncology GroupResearch network
- Sponsor type
- Research network
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Apr 18, 2003
Design
- Study type
- Interventional
- Phase
- Phase 2
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 120 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of chemotherapy in treating patients with early-stage bladder cancer that has not responded to BCG therapy.
Conditions
- Bladder Cancer
Interventions
valrubicinDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida
CCOP - Carle Cancer Center
Urbana, Illinois
Veterans Affairs Medical Center - East Orange
East Orange, New Jersey
Fox Chase Cancer Center
Philadelphia, Pennsylvania
CCOP - MainLine Health
Wynnewood, Pennsylvania
CCOP - Green Bay
Green Bay, Wisconsin
Veterans Affairs Medical Center - Madison
Madison, Wisconsin
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin
Medical College of Wisconsin
Milwaukee, Wisconsin
Veterans Affairs Medical Center - Milwaukee (Zablocki)
Milwaukee, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.